Maryland Medicaid and tirzepatide
Zepbound for weight loss: no. Prior authorization for moderate to severe sleep apnea with obesity (BMI 30 or higher), with a sleep specialist, pulmonologist or other experienced provider. Mounjaro for weight loss: no; for type 2 diabetes Maryland Medicaid must cover it. Read from Maryland Department of Health, Office of Pharmacy Services documents Nov 6, 2026.
In 2025 Maryland Medicaid paid for 20,355 tirzepatide prescriptions (Mounjaro, Zepbound), 14% of its GLP-1 prescriptions and 23rd of the 50 states and DC. It reimbursed $21.3 million before rebates, $1,046 a prescription against $1,032 nationally.
| Brand | Prescriptions | Medicaid paid | Per Rx |
|---|---|---|---|
| Mounjaro | 18,446 | $19.3 million | $1,047 |
| Zepbound | 1,909 | $2.0 million | $1,031 |
Tirzepatide in the states around Maryland
| State | Sell tirzepatide, ship there | Cheapest | Medicaid Rx, 2025 | Medicaid, Zepbound for weight loss |
|---|---|---|---|---|
| Maryland | 17 | $69/moWellmedr | 20,355 | Medicaid Zepbound: No |
| Delaware | 17 | $69/moWellmedr | 15,771 | Medicaid Zepbound: Unclear |
| Pennsylvania | 17 | $69/moWellmedr | 243,243 | Medicaid Zepbound: No |
| Virginia | 17 | $69/moWellmedr | 39,390 | Medicaid Zepbound: Yes |
| West Virginia | 16 | $69/moWellmedr | 2,257 | Medicaid Zepbound: No |
| Washington, DC | not ranked | none verified | 6,039 | Medicaid Zepbound: No |



